Background: Class II molecules of the major histocompatibility complex
become loaded with antigenic peptides after dissociation of invariant
chain-derived peptides (CLIP) from the peptide-binding groove. The hu
man leukocyte antigen (HLA)-DM is a prerequisite for this process, whi
ch takes place in specialised intracellular compartments, HLA-DM catal
yses the peptide-exchange process, simultaneously functioning as a pep
tide 'editor', favouring the presentation of stably binding peptides,
Recently, HLA-DO, an unconventional class II molecule, has been found
associated with HLA-DM in B cells, yet its function has remained elusi
ve, Results: The function of the HLA-DO complex was investigated by ex
pression of both chains of the HLA-DO heterodimer (either alone or fus
ed to green fluorescent protein) in human Mel JuSo cells. Expression o
f HLA-DO resulted in greatly enhanced surface expression of CLIP via H
LA-DR3, the conversion of class II complexes to the SDS-unstable pheno
type and reduced antigen presentation to T-cell clones. Analysis of pe
ptides eluted from HLA-DR3 demonstrated that CLIP was the major peptid
e bound to class II in the HLA-DO transfectants. Peptide exchange assa
ys in vitro revealed that HLA-DO functions directly at the level of cl
ass II peptide loading by inhibiting the catalytic action or HLA-DM, C
onclusions: HLA-DO is a negative modulator of HLA-DM. By stably associ
ating with HLA-DMI the catalytic action of HLA-DM on class II peptide
loading is inhibited, HLA-DO thus affects the peptide repertoire that
is eventually presented to the immune system by MHC class II molecules
.